Hébert: It's time to stop pharma-driven 'free lunch' approach

Share this article:
The Canadian Medical Association Journal ran an editorial excoriating industry-funded education, which editor-in-chief Dr. Paul Hébert said “embellishes the positive elements of studies and downplays the adverse effects.” “It is time to stop the pharma-driven ‘free-lunch' approach” Hébert concluded.
Share this article:

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.